Taysha Gene Therapies Overview
Taysha Gene Therapies Discounted Cash Flow
DCF Analysis for TSHA.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.24
Current Fair Value
$0.24
↓ 96.0% Downside
Overvalued by 96.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison